pyrazines has been researched along with Coronary Disease in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (57.14) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guan, CY; Shi, DZ; Xu, H | 1 |
| Bax, JJ; Cornel, JH; Heine, RJ; van Lingen, A; Veening, MA; Visser, CA; Visser, FC | 1 |
| Huang, X; Jiang, YP; Zang, YM | 1 |
| Baum, RP; Hertel, A; Hör, G; Schröder, O | 1 |
| Liao, F | 1 |
| Amadeo, A; Currò, F; de Pasquale, C | 1 |
| Baughman, KL; Becker, LC; Feldman, AM; Gottlieb, SH; Lee, WK; Strobeck, JE; Weiss, JL | 1 |
| Betton, GR; Isaacs, KR; Joseph, EC | 1 |
| Hamanaka, Y; Hori, M; Inoue, M; Kimura, Y; Kodama, K; Masuyama, T; Mishima, M; Nanto, S | 1 |
| Asanoi, H; Hori, M; Inoue, M; Kawai, C; Kodama, K; Sakurai, T; Sasayama, S | 1 |
| Hori, M; Inoue, M; Iwai, K; Iwakura, K; Kamada, T; Kitakaze, M; Koretsune, Y; Tamai, J | 1 |
| Chapelle, M; Chiche, P | 1 |
| Croxson, MS; John, MB; Neutze, JM | 1 |
| Sanna, GP | 1 |
2 review(s) available for pyrazines and Coronary Disease
| Article | Year |
|---|---|
Herbs of activating blood circulation to remove blood stasis.
Topics: Aged; Animals; Anticoagulants; Blood Viscosity; Cardiovascular Agents; Coronary Disease; Drugs, Chinese Herbal; Fibrinolytic Agents; Hemodynamics; Hemorheology; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrazines; Rats; Rats, Wistar; Stroke; Thrombosis | 2000 |
[Importance of the continuity of anti-hypertension treatment in prevention of ischemic cardiovascular diseases: preliminary note. Controlled study of hypertensive patients treated with amiloride associated with hydrochlorothiazide and chlorthalidone].
Topics: Adult; Aged; Amiloride; Chlorthalidone; Coronary Disease; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Pyrazines | 1978 |
2 trial(s) available for pyrazines and Coronary Disease
| Article | Year |
|---|---|
Combined hyperinsulinaemic glucose clamp and oral acipimox for optimizing metabolic conditions during 18F-fluorodeoxyglucose gated PET cardiac imaging: comparative results.
Topics: Administration, Oral; Coronary Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fluorodeoxyglucose F18; Glucose Clamp Technique; Heart; Humans; Hyperinsulinism; Hypolipidemic Agents; Infusions, Intravenous; Insulin; Male; Middle Aged; Pyrazines; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed | 1998 |
Usefulness of OPC-8212, a quinolinone derivative, for chronic congestive heart failure in patients with ischemic heart disease or idiopathic dilated cardiomyopathy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Disease; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Physical Exertion; Pyrazines; Quality of Life; Quinolines | 1991 |
10 other study(ies) available for pyrazines and Coronary Disease
| Article | Year |
|---|---|
[Clinical application and pharmacological actions of ligustrazine].
Topics: Calcium Channel Blockers; Cerebral Infarction; Coronary Disease; Humans; Pyrazines; Vasodilator Agents | 2003 |
Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols.
Topics: Aged; Blood Glucose; Coronary Disease; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose Clamp Technique; Glucose Tolerance Test; Heart; Humans; Hypolipidemic Agents; Male; Middle Aged; Pyrazines; Tomography, Emission-Computed, Single-Photon | 1997 |
[Study on pharmacokinetic characteristics of tetramethylpyrazine and hemodynamics of heart blood stasis in dogs].
Topics: Animals; Area Under Curve; Blood Pressure; Cardiac Output; Coronary Circulation; Coronary Disease; Dogs; Female; Male; Pyrazines; Vasodilator Agents | 1996 |
Coronary vascular lesions in dogs treated with phosphodiesterase III inhibitors.
Topics: Aminophylline; Animals; Coronary Disease; Coronary Vessels; Digoxin; Dogs; Electrocardiography; Female; Guanidines; Male; Myocardium; Phosphodiesterase Inhibitors; Pyrazines; Pyridazines; Pyridines | 1989 |
Effect of OPC-8212 (2(1H)-quinolinone), a new inotropic agent, on myocardial energy metabolism in patients with coronary heart disease.
Topics: Adult; Aged; Cardiotonic Agents; Coronary Circulation; Coronary Disease; Energy Metabolism; Heart; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Oxygen Consumption; Pyrazines; Quinolines | 1988 |
Acute hemodynamic effects of a new inotropic agent, OPC-8212, on severe congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Cardiac Output; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Disease; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Myocarditis; Pyrazines; Quinolines | 1986 |
Beneficial effect of OPC-8212 (3,4-dihydro-6-(4-(3,4-dimethoxy benzoyl)-1-piperazinyl)-2(1H)-quinolinone on myocardial oxygen consumption in dogs with ischemic heart failure.
Topics: Animals; Coronary Disease; Dogs; Drug Evaluation, Preclinical; Hemodynamics; Oxygen Consumption; Pyrazines; Quinolines | 1986 |
[Potassium depletion in cardiology. Action of amiloride, a potassium sparing diuretic].
Topics: Adult; Aged; Amiloride; Arrhythmias, Cardiac; Coronary Disease; Digitalis Glycosides; Diuretics; Female; Heart Diseases; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Potassium Deficiency; Pyrazines | 1973 |
Exchangeable potassium in heart disease: long-term effects of potassium supplements and amiloride.
Topics: Adult; Aged; Amiloride; Coronary Disease; Diuretics; Erythrocytes; Female; Furosemide; Heart Diseases; Heart Valve Diseases; Humans; Male; Middle Aged; Potassium; Potassium Isotopes; Pyrazines; Uric Acid | 1972 |
[Modern and rational use of diuretics in cardiology].
Topics: Coronary Disease; Diuretics; Ethacrynic Acid; Furosemide; Glucocorticoids; Heart Diseases; Humans; Kidney; Pulmonary Edema; Pyrazines; Sulfonamides; Triamterene; Triazines | 1969 |